Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 23 (2007), Issue 1-2, Pages 89-96
http://dx.doi.org/10.1155/2007/293138

Cancer Diagnosis, Risk Assessment and Prediction of Therapeutic Response by Means of DNA Methylation Markers

Heidi Fiegl1,2 and Karim Elmasry1

1Translational Research Laboratory, Department of Gynaecological Oncology, Institute of Women’s Health, UCL, London, UK
2Biocentre Innsbruck, Division of Cell Biology, Medical University Innsbruck, Austria

Received 18 January 2007; Accepted 18 January 2007

Copyright © 2007 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Heidi Fiegl and Karim Elmasry, “Cancer Diagnosis, Risk Assessment and Prediction of Therapeutic Response by Means of DNA Methylation Markers,” Disease Markers, vol. 23, no. 1-2, pp. 89-96, 2007. doi:10.1155/2007/293138